Nemaura Medical Past Earnings Performance
Past criteria checks 0/6
Nemaura Medical's earnings have been declining at an average annual rate of -26.7%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 48.6% per year.
Key information
-26.7%
Earnings growth rate
-20.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 48.6% |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Nemaura Medical GAAP EPS of -$0.17
Aug 15Nemaura Medical GAAP EPS of -$0.59 misses by $0.12, revenue of $0.51M
Jun 30Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market
Mar 10Nemaura Medical (NASDAQ:NMRD) Has Debt But No Earnings; Should You Worry?
Nov 17
Nemaura Medical: From Believer To Skeptic
Sep 20Nemaura: Wearable Monitoring Patches For Type-2 Diabetics Could Be An Inspired Move
Jul 02Nemaura Medical rallies on 200K sugarBEAT sensors order
May 05Nemaura Medical: Lowering Glucose Levels Will Increase Share Price
Feb 03How Much Of Nemaura Medical Inc. (NASDAQ:NMRD) Do Insiders Own?
Dec 22
Revenue & Expenses BreakdownBeta
How Nemaura Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -11 | 8 | 2 |
| 30 Sep 23 | 0 | -10 | 6 | 2 |
| 30 Jun 23 | 0 | -13 | 6 | 2 |
| 31 Mar 23 | 0 | -14 | 6 | 2 |
| 31 Dec 22 | 0 | -13 | 4 | 2 |
| 30 Sep 22 | 1 | -15 | 6 | 2 |
| 30 Jun 22 | 1 | -14 | 6 | 2 |
| 31 Mar 22 | 1 | -14 | 6 | 2 |
| 31 Dec 21 | 0 | -12 | 5 | 1 |
| 30 Sep 21 | 0 | -10 | 4 | 1 |
| 30 Jun 21 | 0 | -9 | 4 | 2 |
| 31 Mar 21 | 0 | -6 | 3 | 2 |
| 31 Dec 20 | 0 | -5 | 3 | 2 |
| 30 Sep 20 | 0 | -4 | 3 | 2 |
| 30 Jun 20 | 0 | -4 | 3 | 2 |
| 31 Mar 20 | 0 | -4 | 3 | 2 |
| 31 Dec 19 | 0 | -4 | 3 | 2 |
| 30 Sep 19 | 0 | -5 | 3 | 2 |
| 30 Jun 19 | 0 | -5 | 3 | 2 |
| 31 Mar 19 | 0 | -4 | 2 | 2 |
| 31 Dec 18 | 0 | -3 | 2 | 2 |
| 30 Sep 18 | 0 | -3 | 1 | 2 |
| 30 Jun 18 | 0 | -2 | 1 | 1 |
| 31 Mar 18 | 0 | -2 | 1 | 1 |
| 31 Dec 17 | 0 | -2 | 1 | 1 |
| 30 Sep 17 | 0 | -2 | 1 | 1 |
| 30 Jun 17 | 0 | -1 | 1 | 1 |
| 31 Mar 17 | 0 | -2 | 1 | 1 |
| 31 Dec 16 | 0 | -2 | 1 | 1 |
| 30 Sep 16 | 0 | -2 | 1 | 1 |
| 30 Jun 16 | 0 | -2 | 1 | 1 |
| 31 Mar 16 | 0 | -2 | 1 | 1 |
| 31 Dec 15 | 0 | -2 | 1 | 1 |
| 30 Sep 15 | 0 | -1 | 0 | 1 |
| 30 Jun 15 | 0 | -1 | 1 | 1 |
| 31 Mar 15 | 0 | -1 | 0 | 1 |
| 31 Dec 14 | 0 | -1 | 0 | 1 |
| 30 Sep 14 | 0 | -1 | 0 | 1 |
| 30 Jun 14 | 0 | -1 | 0 | 0 |
| 31 Mar 14 | 0 | -1 | 0 | 0 |
Quality Earnings: NMRD is currently unprofitable.
Growing Profit Margin: NMRD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NMRD is unprofitable, and losses have increased over the past 5 years at a rate of 26.7% per year.
Accelerating Growth: Unable to compare NMRD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NMRD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: NMRD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.